Recently, the US FDA announced the approval of Merck's cervical cancer prevention vaccine "Jia Da Xiu" to prevent vulvar and vaginal cancer caused by human papillomavirus (HPV) in women aged 9 to 26 and women. 70% of cervical cancers are caused by these two HPV viruses, and they can also induce some vulvar and vaginal cancer, but the specific proportion has not been confirmed.
Jesse L. Goodman, director of the FDA Center for Biologics Assessment and Research, MD, and M.Sc., said: There is strong evidence that “Jia Da Xiuâ€, which prevents cervical cancer, can help prevent vulva and vagina induced by the same virus. cancer".
FDAzui first approved "Jia Da Xiu" in 2006 to prevent cervical and vaginal precancerous lesions caused by HPV 6, 11, 16 and 18 in cervical cancer caused by 16 and 18 HPV viruses in girls and women aged 9 to 26 years old. And genital warts caused by HPV type 6, 11 type.
According to the US Centers for Disease Control and Prevention (CDC), HPV is a common infectious virus transmitted by sexual behavior in the United States. Every year, 6.2 million Americans are infected with genital HPV. Most women's own immune system removes the HPV virus, thereby eliminating the risk of serious disease. However, some HPV types can cause abnormal proliferation of cells in the cervix, vagina, vulva and other areas, and may cause cancer after several years.
Hospital/Clinic/Drugstore Equipment
Lightweight Wheelchair,Folding Wheelchair,Manual Wheelchair,Portable Wheelchair
Surgimed Medical Supplies Co.,Ltd , https://www.surgimedcn.com